These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8558941)

  • 1. High levels of Ca(2+)-independent endonuclease activity capable of producing nucleosomal-size DNA fragmentation in non-adherent marrow mononuclear cells from patients with myelodysplastic syndromes and acute myelogenous leukemia.
    Kawabata H; Anzai N; Ueda Y; Masutani H; Hirama T; Yoshida Y; Okuma M
    Leukemia; 1996 Jan; 10(1):67-73. PubMed ID: 8558941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
    Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
    Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C; Loher F; Zang C; Ismair MG; Petrides PE
    Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase activity in myelodysplastic syndromes.
    Gürkan E; Tanriverdi K; Başlamişli F
    Leuk Res; 2005 Oct; 29(10):1131-9. PubMed ID: 16111531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromes.
    Travaglino E; Benatti C; Malcovati L; Della Porta MG; Gallì A; Bonetti E; Rosti V; Cazzola M; Invernizzi R
    Eur J Haematol; 2008 Mar; 80(3):216-26. PubMed ID: 18081721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mg2+- or Mn2+-dependent endonuclease activities of human myeloid leukemia cells capable of producing nucleosomal-size DNA fragmentation.
    Kawabata H; Anzai N; Masutani H; Hirama T; Hishita T; Dodo M; Masuda T; Yoshida Y; Okuma M
    Biochem Biophys Res Commun; 1997 Apr; 233(1):133-8. PubMed ID: 9144410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KIS induces proliferation and the cell cycle progression through the phosphorylation of p27Kip1 in leukemia cells.
    Nakamura S; Okinaka K; Hirano I; Ono T; Sugimoto Y; Shigeno K; Fujisawa S; Shinjo K; Ohnishi K
    Leuk Res; 2008 Sep; 32(9):1358-65. PubMed ID: 18384876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Apoptosis in MDS].
    Anzai N; Kawabata H; Hishita T; Ueda Y; Yoshida Y
    Rinsho Ketsueki; 1996 Jul; 37(7):536-41. PubMed ID: 8779768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro effects of IL-2 on NK-activity, clonogenic potential, blast cell proliferation and cytokine release of MDS bone marrow patients.
    Cortelezzi A; Sarina B; Cattaneo C; Pomati M; Silvestris I; Soligo D; Calori R; Di Stefano M; Hu C; Monza M; Radelli L; Maiolo AT
    Leukemia; 1996 Jul; 10(7):1181-9. PubMed ID: 8684000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of MCM2 in myelodysplastic syndromes: association with bone marrow cell apoptosis and peripheral cytopenia.
    Suzuki S; Kurata M; Abe S; Miyazawa R; Murayama T; Hidaka M; Yamamoto K; Kitagawa M
    Exp Mol Pathol; 2012 Feb; 92(1):160-6. PubMed ID: 22115939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of type 1 insulin-like growth factor receptor in marrow nucleated cells in malignant hematological disorders: correlation with apoptosis.
    Qi H; Xiao L; Lingyun W; Ying T; Yi-Zhi L; Shao-Xu Y; Quan P
    Ann Hematol; 2006 Feb; 85(2):95-101. PubMed ID: 16328478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation.
    Follo MY; Mongiorgi S; Bosi C; Cappellini A; Finelli C; Chiarini F; Papa V; Libra M; Martinelli G; Cocco L; Martelli AM
    Cancer Res; 2007 May; 67(9):4287-94. PubMed ID: 17483341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DCC protein expression in hematopoietic cell populations and its relation to leukemogenesis.
    Inokuchi K; Miyake K; Takahashi H; Dan K; Nomura T
    J Clin Invest; 1996 Feb; 97(3):852-7. PubMed ID: 8609244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes.
    Suárez L; Vidriales MB; García-Laraña J; Sanz G; Moreno MJ; López A; Barrena S; Martínez R; Tormo M; Palomera L; Lavilla E; López-Berges MC; de Santiago M; de Equiza ME; Miguel JF; Orfao A
    Clin Cancer Res; 2004 Nov; 10(22):7599-606. PubMed ID: 15569991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent p53 overexpression in therapy related myelodysplastic syndromes and acute myeloid leukemias: an immunohistochemical study of bone marrow biopsies.
    Orazi A; Cattoretti G; Heerema NA; Sozzi G; John K; Neiman RS
    Mod Pathol; 1993 Sep; 6(5):521-5. PubMed ID: 8248107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivin expression in "low-risk" and "high-risk" myelodysplastic syndromes.
    Gianelli U; Fracchiolla NS; Cortelezzi A; Pellegrini C; Savi F; Moro A; Grimoldi MG; Deliliers GL; Coggi G; Bosari S
    Ann Hematol; 2007 Mar; 86(3):185-9. PubMed ID: 17124585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous down-regulation of Fas-associated phosphatase-1 may contribute to excessive apoptosis in myelodysplastic marrows.
    Mundle SD; Mativi BY; Bagai K; Feldman G; Cheema P; Gautam U; Reza S; Cartlidge JD; Venugopal P; Shetty V; Gregory SA; Robin E; Rifkin S; Shah R; Raza A
    Int J Hematol; 1999 Aug; 70(2):83-90. PubMed ID: 10497846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the prognostic relevance of L-selectin and ICAM1 expression in myelodysplastic syndromes.
    Buccisano F; Maurillo L; Tamburini A; Del Poeta G; Del Principe MI; Ammatuna E; Consalvo MI; Campagna S; Ottaviani L; Sarlo C; Renzi D; Faccia S; Fraboni D; Lo Coco F; Amadori S; Venditti A
    Eur J Haematol; 2008 Feb; 80(2):107-14. PubMed ID: 18028430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase activity in myelodysplastic syndrome.
    Fu C; Chen Z
    Chin Med J (Engl); 2002 Oct; 115(10):1475-8. PubMed ID: 12490090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes.
    Lundberg LG; Hellström-Lindberg E; Kanter-Lewensohn L; Lerner R; Palmblad J
    Leuk Res; 2006 Mar; 30(3):247-53. PubMed ID: 16099505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.